IGC PHARMA, INC. (IGC) Operating margin 2016–2025
IGC PHARMA, INC. (IGC) operating margin by fiscal year — reported operating income divided by reported revenue.
-585.8%FY2025 · since FY2016: -45.6% → -585.8%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -585.8% | +142.6 pp |
| FY2024 | -728.5% | +541.7 pp |
| FY2023 | -1270.1% | +2616.0 pp |
| FY2022 | -3886.1% | -2914.7 pp |
| FY2021 | -971.5% | -802.9 pp |
| FY2020 | -168.6% | -77.8 pp |
| FY2019 | -90.8% | -9.2 pp |
| FY2018 | -81.6% | +272.4 pp |
| FY2017 | -354.0% | -308.3 pp |
| FY2016 | -45.6% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice